Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-329

Known as: MK 329, MK329 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
1 In the pig, the secretory response of the pancreas is not inhibited by the antagonist MK329 suggesting that cholecystokininA… Expand
Highly Cited
1993
Highly Cited
1993
We employed quantitative receptor autoradiography to analyze pharmacological properties of 125I-Bolton Hunter cholecystokinin… Expand
Highly Cited
1992
Highly Cited
1992
The role of the vagal and spinal afferent innervation in the inhibition of gastric emptying induced by duodenal perfusion with a… Expand
Highly Cited
1990
Highly Cited
1990
In vitro autoradiography was performed in order to visualize cholecystokinin-A (CCK-A) receptors in sections of Cynomolgus monkey… Expand
  • figure 3
Highly Cited
1990
Highly Cited
1990
Cholecystokinin (CCK) receptor binding was measured in rodent and primate brain and spinal cord using 125I-Bolton Hunter CCK-8… Expand
Highly Cited
1990
Highly Cited
1990
The effects of the selective CCK-A antagonist L-365,031 and the selective CCK-B antagonist L-365,260 on morphine analgesia and… Expand
Highly Cited
1990
Highly Cited
1990
The cholecystokinin (CCK) receptor antagonist MK-329 (previously L364,718) was administered intravenously (IV) (17.5-140… Expand
Highly Cited
1990
Highly Cited
1990
1 Experiments were conducted to determine whether or not the effect of (+)‐fenfluramine (3.0 mg kg−1, i.p.) on food intake can be… Expand
Highly Cited
1989
Highly Cited
1989
To explore the physiology of cholecystokinin (CCK) in humans, we investigated the effect on gallbladder contraction and gastric… Expand
  • figure 2
  • figure 3
  • figure 5
Review
1989
Review
1989
&NA; The octapeptide form of CCK predominates in the central nervous system (CNS) of mammalian species, including man. Many of… Expand